Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-10-27

Clinical Trial Update: A Study On The Efficacy Of Macugen Injections In Patients With Neovascular Age-Related Macular Degeneration In Real Life.

View source ↗

Summary

A completed real-life study assessing the efficacy of Macugen injections in neovascular age-related macular degeneration (AMD).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Macugen (pegaptanib sodium)

Snippet

Sponsor: Pfizer | Conditions: Neovascular Age-related Macular Degeneration | Status: COMPLETED | Results posted: 2010-10-27